Trial Site Detail

 

Drug:
QINLOCK Ripretinib DCC-2618
Trial:
Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies (invictus)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

University of Chicago

5841 S. Maryland Ave     
Chicago , IL 60637
USA

 

Principal Investigator:
Hedy Kindler, MD
Contact:
Clinical Trials Office, 773-834-7424
Activation Status of this Site:
Closed
Notes about this Site:
University of Chicago Website:
https://med-www02.bsd.uchicago.edu/crc_web/SR/internet/DiseaseSites.aspx

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.